Randomized Controlled Trials of COX-2 Inhibitors: An Analysis of Doses Used and Trends Over Time to Investigate Implications for Comparative Safety

Author： Stefansdottir Gudrun   De Bruin Marie L.   Knol Mirjam J.   Grobbee Diederick E.   Leufkens Hubert G.M.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.9, 2011-09, pp. : 783-792

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized Controlled Trials and Assessment of Drug Safety

By Clark David W.J.  

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1057-1061

Adis International

Access to resources Recommend Favorite

Gastrointestinal Safety of Selective COX-2 Inhibitors

By  

Current Pharmaceutical Design, Vol. 8, Iss. 12, 2002-06 ,pp. : 1077-1089

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Dipeptidyl Peptidase-4 Inhibitors on Plasma Adiponectin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

By  

Current Medicinal Chemistry, Vol. 23, Iss. 13, 2016-04 ,pp. : 1356-1369

Bentham Science Publishers

Access to resources Recommend Favorite

Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials

By Essex Margaret Noyes   Zhang Richard Y   Berger Manuela F   Upadhyay Sameer   Park Peter W  

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 465-477

Informa Healthcare

Access to resources Recommend Favorite

Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinson's Disease: Meta-Analysis of Randomized Controlled Trials

By Kulisevsky Jaime   Pagonabarraga Javier  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 147-161

Adis International

Access to resources Recommend Favorite